Filing Details

Accession Number:
0001562180-22-007667
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-15 16:04:20
Reporting Period:
2022-11-10
Accepted Time:
2022-11-15 16:04:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597553 Sage Therapeutics Inc. SAGE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1291963 E Barry Greene C/O Sage Therapeutics, Inc.
215 First Street
Cambridge MA 02142
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-11-10 14,500 $34.48 46,940 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $34.19 USD to $34.86 USD. The price reported above reflects the weighted average purchase price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.